Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, ...

NVIDIA BioNeMo NVIDIA today announced a major expansion of NVIDIA BioNeMo, an open development platform that enables ...

The new company combines Tahoe’s AI-powered target discovery engine with Alloy’s industry-leading ADC development ...

Nvidia and Eli Lilly team up to revolutionize drug discovery with a $1 billion artificial intelligence lab, combining AI and ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

In a groundbreaking announcement, tech giant NVIDIA and pharmaceutical leader Eli Lilly and Co. are joining forces to establish an artificial intelligence lab aimed at transforming drug discovery.

NVIDIA and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to ...

For decades, the process of drug discovery has been a prolonged, costly, and unpredictable endeavor — an effort that ...

At Fast Company and Johns Hopkins University's World Changing Ideas Summit in November, leaders shared what's top of mind for ...

The partnership between Nvidia and Eli Lilly is not just about financial investment; it represents a new blueprint for how drugs will be developed in the future. By combining their resources and ...

Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help accelerate drug discovery ...

Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.